GILEAD SCIENCES INC (GILD) Stock Fundamental Analysis

NASDAQ:GILD • US3755581036

151.4 USD
+0.28 (+0.19%)
At close: Feb 20, 2026
151.41 USD
+0.01 (+0.01%)
After Hours: 2/20/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, GILD scores 6 out of 10 in our fundamental rating. GILD was compared to 520 industry peers in the Biotechnology industry. GILD has an excellent profitability rating, but there are some minor concerns on its financial health. GILD has a correct valuation and a medium growth rate. Finally GILD also has an excellent dividend rating. These ratings could make GILD a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • GILD had positive earnings in the past year.
  • In the past year GILD had a positive cash flow from operations.
  • In the past 5 years GILD has always been profitable.
  • GILD had a positive operating cash flow in 4 of the past 5 years.
GILD Yearly Net Income VS EBIT VS OCF VS FCFGILD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.86%, GILD belongs to the top of the industry, outperforming 94.82% of the companies in the same industry.
  • GILD has a better Return On Equity (37.80%) than 98.08% of its industry peers.
  • The Return On Invested Capital of GILD (19.16%) is better than 97.50% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GILD is in line with the industry average of 18.69%.
  • The last Return On Invested Capital (19.16%) for GILD is above the 3 year average (17.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 19.16%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.64%
ROE(5y)23.22%
ROIC(3y)17.58%
ROIC(5y)16.77%
GILD Yearly ROA, ROE, ROICGILD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • GILD has a better Profit Margin (27.88%) than 95.39% of its industry peers.
  • In the last couple of years the Profit Margin of GILD has grown nicely.
  • Looking at the Operating Margin, with a value of 38.96%, GILD belongs to the top of the industry, outperforming 98.27% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GILD has remained more or less at the same level.
  • The Gross Margin of GILD (78.72%) is better than 85.22% of its industry peers.
  • In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y-1.28%
OM growth 5Y-0.04%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GILD Yearly Profit, Operating, Gross MarginsGILD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GILD is creating value.
  • Compared to 1 year ago, GILD has less shares outstanding
  • The number of shares outstanding for GILD has been reduced compared to 5 years ago.
  • There is no outstanding debt for GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GILD Yearly Shares OutstandingGILD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GILD Yearly Total Debt VS Total AssetsGILD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC2.32
WACC8.26%
GILD Yearly LT Debt VS Equity VS FCFGILD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that GILD should not have too much problems paying its short term obligations.
  • GILD has a Current ratio of 1.53. This is amonst the worse of the industry: GILD underperforms 80.42% of its industry peers.
  • GILD has a Quick Ratio of 1.17. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.17, GILD is doing worse than 83.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
GILD Yearly Current Assets VS Current LiabilitesGILD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
  • GILD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.83% yearly.
  • The Revenue has been growing slightly by 2.40% in the past year.
  • The Revenue has been growing slightly by 3.58% on average over the past years.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.47% on average over the next years. This is quite good.
  • Based on estimates for the next years, GILD will show a small growth in Revenue. The Revenue will grow by 4.32% on average per year.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GILD Yearly Revenue VS EstimatesGILD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GILD Yearly EPS VS EstimatesGILD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.58, which indicates a rather expensive current valuation of GILD.
  • GILD's Price/Earnings ratio is rather cheap when compared to the industry. GILD is cheaper than 94.82% of the companies in the same industry.
  • GILD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.99.
  • GILD is valuated correctly with a Price/Forward Earnings ratio of 16.97.
  • 94.82% of the companies in the same industry are more expensive than GILD, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, GILD is valued a bit cheaper.
Industry RankSector Rank
PE 18.58
Fwd PE 16.97
GILD Price Earnings VS Forward Price EarningsGILD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, GILD is valued cheaper than 95.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.73
EV/EBITDA N/A
GILD Per share dataGILD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • GILD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.97
PEG (5Y)6.57
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.15%, GILD has a reasonable but not impressive dividend return.
  • GILD's Dividend Yield is rather good when compared to the industry average which is at 1.17. GILD pays more dividend than 98.46% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, GILD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.15%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 4.45%.
  • GILD has paid a dividend for at least 10 years, which is a reliable track record.
  • As GILD did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.45%
Div Incr Years9
Div Non Decr Years9
GILD Yearly Dividends per shareGILD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
GILD Yearly Income VS Free CF VS DividendGILD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GILD Dividend Payout.GILD Dividend Payout, showing the Payout Ratio.GILD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILEAD SCIENCES INC

NASDAQ:GILD (2/20/2026, 8:00:01 PM)

After market: 151.41 +0.01 (+0.01%)

151.4

+0.28 (+0.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner Change0.12%
Ins Owners0.07%
Ins Owner Change0.67%
Market Cap187.84B
Revenue(TTM)29.44B
Net Income(TTM)8.11B
Analysts81.62
Price Target142.32 (-6%)
Short Float %1.91%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield 2.15%
Yearly Dividend3.14
Dividend Growth(5Y)4.45%
DP12%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)5.14%
PT rev (3m)9.72%
EPS NQ rev (1m)-2.64%
EPS NQ rev (3m)-3.29%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)0.64%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 18.58
Fwd PE 16.97
P/S 6.46
P/FCF 19.73
P/OCF 19.43
P/B 8.75
P/tB N/A
EV/EBITDA N/A
EPS(TTM)8.15
EY5.38%
EPS(NY)8.92
Fwd EY5.89%
FCF(TTM)7.67
FCFY5.07%
OCF(TTM)7.79
OCFY5.15%
SpS23.44
BVpS17.29
TBVpS-3.89
PEG (NY)1.97
PEG (5Y)6.57
Graham Number56.31
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 19.16%
ROICexc 24.01%
ROICexgc 83.57%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.64%
ROE(5y)23.22%
ROIC(3y)17.58%
ROIC(5y)16.77%
ROICexc(3y)21.93%
ROICexc(5y)20.23%
ROICexgc(3y)88.64%
ROICexgc(5y)94.14%
ROCE(3y)22.49%
ROCE(5y)21.46%
ROICexgc growth 3Y-8.52%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y8.92%
ROICexc growth 5Y10.03%
OM growth 3Y-1.28%
OM growth 5Y-0.04%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC8.26%
ROIC/WACC2.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%
EBIT growth 1Y4.49%
EBIT growth 3Y1.26%
EBIT growth 5Y3.55%
EBIT Next Year16.04%
EBIT Next 3Y12.29%
EBIT Next 5Y8.69%
FCF growth 1Y0.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.54%
OCF growth 3YN/A
OCF growth 5YN/A

GILEAD SCIENCES INC / GILD FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?

ChartMill assigns a fundamental rating of 6 / 10 to GILD.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 5 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.


How profitable is GILEAD SCIENCES INC (GILD) stock?

GILEAD SCIENCES INC (GILD) has a profitability rating of 8 / 10.


What is the valuation of GILEAD SCIENCES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (GILD) is 18.58 and the Price/Book (PB) ratio is 8.75.


How sustainable is the dividend of GILEAD SCIENCES INC (GILD) stock?

The dividend rating of GILEAD SCIENCES INC (GILD) is 7 / 10 and the dividend payout ratio is 12%.